SCHEMBL31518665

SCHEMBL31518665

C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 7/20 0.46
▸ REN P00797 4/20 0.40
▸ DPP7 Q9UHL4 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ F2 P00734 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ LTA4H P09960 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PEPD P12955 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ THPO P40225 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ ACE2 Q9BYF1 1/20 0.38
▸ CMA1 P23946 1/20 0.37
▸ PRCP P42785 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6665556 0.86 ACE (0.46) ACERENKDM4EF2LMNA
SCHEMBL6665561 0.86 ACE (0.46) ACERENKDM4EF2LMNA
SCHEMBL31518674 0.86 XIAP (0.37) ACERENCMA1
SCHEMBL30052400 0.86 ACE (0.48) ACERENKDM4EF2LMNA
SCHEMBL31406958 0.86 ACE (0.39) ACERENDPP7CMA1
SCHEMBL30785877 0.84 PREP (0.40) ACEDPP7F2PRCP
SCHEMBL30697798 0.84 PREP (0.40) ACEDPP7F2PRCP
SCHEMBL17209377 0.83 TRHR (0.43) DPP7
SCHEMBL31195363 0.83 REN (0.43) ACERENKDM4EF2LMNA
SCHEMBL32689780 0.83 TERT (0.36) ACERENCMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025098490-A1 POLYPEPTIDE AND USE THEREOF 四川好医生攀西药业有限责任公司 2025-05-15 — — WO claimed
WO-2025098490-A1 POLYPEPTIDE AND USE THEREOF 四川好医生攀西药业有限责任公司 2025-05-15 — — WO disclosed
Send feedback